Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. N-(2-(3-methoxyphenyl)-2-ethylbutyl-(1))-gamma-hydroxybutyramide
1. Embutane
2. 15687-14-6
3. Embutramid
4. N-[2-ethyl-2-(3-methoxyphenyl)butyl]-4-hydroxybutanamide
5. T-61
6. Butanamide, N-(2-ethyl-2-(3-methoxyphenyl)butyl)-4-hydroxy-
7. Hoe 18 680
8. 3p4tqg94t1
9. Hoe-18680
10. Hoe-18-680
11. Embutramida
12. Embutramidum
13. Butanamide, N-[2-ethyl-2-(3-methoxyphenyl)butyl]-4-hydroxy-
14. N-(.beta.,.beta.-diethyl-m-methoxyphenethyl)-4-hydroxybutyramide
15. Embutramidum [inn-latin]
16. Embutramida [inn-spanish]
17. Embutramide [usan:inn:ban]
18. Einecs 239-780-4
19. Hoe 18,680
20. Unii-3p4tqg94t1
21. Tributane
22. Embutane (tn)
23. N-(beta,beta-diethyl-m-methoxyphenethyl)-4-hydroxybutyramide
24. Embutramide [inn]
25. Embutramide (usan/inn)
26. Embutramide [usan]
27. Dsstox_cid_31443
28. Dsstox_rid_97329
29. Embutramide [mart.]
30. Dsstox_gsid_57654
31. Schembl294224
32. Dea No. 2020
33. Embutramid [green Book]
34. Chembl2104668
35. Dtxsid7057654
36. Zinc2018676
37. Tox21_113716
38. Hy-u00009
39. Cs-6631
40. Db01487
41. Embutramide 1.0 Mg/ml In Acetonitrile
42. Hoe-18 680
43. Ncgc00253572-01
44. Cas-15687-14-6
45. D03984
46. Q908240
47. N-[2-ethyl-2-(3-methoxyphenyl)butyl]-4-hydroxybutanamide #
48. N-(.beta.,.beta.-dimethyl-m-methoxyphenethyl)-4-hydroxybutyramide
| Molecular Weight | 293.4 g/mol |
|---|---|
| Molecular Formula | C17H27NO3 |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 9 |
| Exact Mass | 293.19909372 g/mol |
| Monoisotopic Mass | 293.19909372 g/mol |
| Topological Polar Surface Area | 58.6 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 302 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Embutramide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Embutramide, including repackagers and relabelers. The FDA regulates Embutramide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Embutramide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Embutramide supplier is an individual or a company that provides Embutramide active pharmaceutical ingredient (API) or Embutramide finished formulations upon request. The Embutramide suppliers may include Embutramide API manufacturers, exporters, distributors and traders.
click here to find a list of Embutramide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Embutramide DMF (Drug Master File) is a document detailing the whole manufacturing process of Embutramide active pharmaceutical ingredient (API) in detail. Different forms of Embutramide DMFs exist exist since differing nations have different regulations, such as Embutramide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Embutramide DMF submitted to regulatory agencies in the US is known as a USDMF. Embutramide USDMF includes data on Embutramide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Embutramide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Embutramide suppliers with USDMF on PharmaCompass.
Embutramide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Embutramide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Embutramide GMP manufacturer or Embutramide GMP API supplier for your needs.
A Embutramide CoA (Certificate of Analysis) is a formal document that attests to Embutramide's compliance with Embutramide specifications and serves as a tool for batch-level quality control.
Embutramide CoA mostly includes findings from lab analyses of a specific batch. For each Embutramide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Embutramide may be tested according to a variety of international standards, such as European Pharmacopoeia (Embutramide EP), Embutramide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Embutramide USP).
LOOKING FOR A SUPPLIER?
